This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2017
Title: The Innovations of Andrew J. Greenspan: Pioneering H-Receptor Modulators
Introduction
Andrew J. Greenspan is an innovative inventor based in San Diego, CA, whose contributions to the pharmaceutical field have been noteworthy. With a total of two patents to his name, Greenspan is making strides in the development of compounds that target the histamine H4 receptor, which is significant for addressing various medical conditions.
Latest Patents
Greenspan's latest patents revolve around diamino-pyridine, pyrimidine, and pyridazine compounds, proposed for use as H-receptor modulators. These compounds are particularly applicable in pharmaceutical compositions and methods designed to treat disease states, disorders, and conditions that are mediated by H-receptor activity, including allergies, asthma, autoimmune diseases, and pruritus. His work in this area showcases his commitment to advancing therapeutic options that could significantly enhance patient care.
Career Highlights
Andrew J. Greenspan is currently affiliated with Janssen Pharmaceutica NV, a company recognized for its emphasis on innovative pharmaceuticals. During his career, he has focused on developing novel compounds that can improve treatment strategies for various health issues, further emphasizing his role as a leading inventor in the pharmaceutical industry.
Collaborations
In his endeavors, Greenspan has collaborated with notable colleagues such as Hui Cai and Frank Chavez. These partnerships are critical for pushing the boundaries of current medical research and ensuring the effectiveness of inventions aimed at addressing significant health challenges.
Conclusion
Andrew J. Greenspan's contributions to the field of pharmaceuticals through his patents and collaborative efforts reflect his dedication to innovation and advancement in medicine. His work on H-receptor modulators holds promise for improving treatments for conditions that currently pose challenges in clinical settings. The impact of his inventions could pave the way for new therapeutic avenues in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile